SironRx Hires Evan Facher as CEO
Cleveland, OH--SironRx, a spin-off of Juventas Therapeutics that is developing wound healing technology, has hired Evan Facher is CEO. A veteran of Cleveland-based stem cell company Athersys, Facher has for the last eight years held a variety of executive roles at MedRad, a division of Bayer Healthcare.
SironRx is developing wound healing technology that is based on the work of Marc Penn, M.D., while he was at the Cleveland Clinic Foundation. The company recently received regulatory clearance to begin a Phase I clinical study of its technology in patients who have undergone a median sternotomy. Read more...
Find Out More About ESP
Mike Bunker manages the Early Stage Partners investment in SironRx